AlbaniaTuberculosis profile
Population  2014 2.9 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.017 (0.012–0.023) 0.58 (0.4–0.79)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.07 (0.05–0.09)
Prevalence  (includes HIV+TB) 0.75 (0.35–1.3) 26 (12–45)
Incidence  (includes HIV+TB) 0.54 (0.46–0.63) 19 (16–22)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.12 (0.09–0.15)
         
Case detection, all forms (%) 75 (65–88)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 0.58 (0.02–3.2) 0 (0–22)
MDR-TB cases among notified pulmonary
TB cases
1 (0–8) 0 (0–4)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 159   16
Pulmonary, clinically diagnosed 83   2
Extrapulmonary 145   3
       
Total new and relapse 408    
Previously treated, excluding relapses 0    
Total cases notified 408    
Among 408 new and relapse cases:
21 (5%) cases aged under 15 years; male:female ratio: 2.0
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 21 (13%) 8 (38%) 29
Laboratory-confirmed RR-/MDR-TB cases     3
Patients started on MDR-TB treatment ***     0
TB/HIV 2014 Number (%)
TB patients with known HIV status 41 (10)
HIV-positive TB patients 2 (5)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 2 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 2 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (88) 472
Previously treated cases, excluding relapse, registered in 2013    
HIV-positive TB cases, all types, registered in 2013 (50) 2
RR-/MDR-TB cases started on second-line treatment in 2012    
XDR-TB cases started on second-line treatment in 2012    
Laboratories 2014  
Is second-line drug susceptibility testing available? No
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-07-27 Data: www.who.int/tb/data